Docoh
Loading...

68 results

Filter options loading...
Top filers
Top filing types
Recent filing years
DEF 14A
PRPO Precipio Inc
29 Apr 21
Definitive proxy
4:31pm
expert” under the rules adopted by the SEC and the Sarbanes Oxley Act of 2002. The Audit Committee met eight (8) times during the fiscal year ended
8-K
EX-1.01
PRPO Precipio Inc
2 Apr 21
Entry into a Material Definitive Agreement
3:00pm
expert,” as such term is defined under Regulation S-K and the listing rules of the Exchange. In addition, at least a majority of the persons serving
424B5
PRPO Precipio Inc
2 Apr 21
Prospectus supplement for primary offering
2:00pm
that will further broaden and strengthen our academic expert network. Our cutting-edge liquid biopsy technology, ICP, enables detection of abnormalities
10-K
2020 FY
PRPO Precipio Inc
29 Mar 21
Annual report
4:29pm
subspecialist expertise to be aggregated. Utilizing academic expert pathologists across multiple academic institutions enables the Company to provide access … developed. The goal is to provide them with a diagnosis rendered by an expert and as required an academic subspecialist. The second function of our
424B3
PRPO Precipio Inc
7 Jul 20
Prospectus supplement
5:27pm
that will further broaden and strengthen our academic expert network. Our cutting-edge liquid biopsy technology, ICP, enables detection of abnormalities
S-1
PRPO Precipio Inc
26 Jun 20
IPO registration
5:18pm
academic expert network. Our cutting-edge liquid biopsy technology, ICP, enables detection of abnormalities in blood samples down to as low as .01%. Our
DEF 14A
PRPO Precipio Inc
29 Apr 20
Definitive proxy
4:32pm
. The Board has determined that Ms. LaPorte, Dr. Fisher and Mr. Rimer each qualifies as an “audit committee financial expert” under the rules adopted
424B3
PRPO Precipio Inc
13 Apr 20
Prospectus supplement
4:55pm
with premiere academic institutions during 2020 that will further broaden and strengthen our academic expert network. Our cutting-edge liquid biopsy
S-3/A
PRPO Precipio Inc
9 Apr 20
Shelf registration (amended)
1:53pm
and strengthen our academic expert network. Our cutting-edge liquid biopsy technology, ICP, enables detection of abnormalities in blood samples down to as low
S-1/A
PRPO Precipio Inc
8 Apr 20
IPO registration (amended)
3:41pm
with premiere academic institutions during 2020 that will further broaden and strengthen our academic expert network. Our cutting-edge liquid biopsy technology
S-3
PRPO Precipio Inc
27 Mar 20
Shelf registration
4:51pm
expert network. Our cutting-edge liquid biopsy technology, ICP, enables detection of abnormalities in blood samples down to as low as .01%. Our
S-1
PRPO Precipio Inc
27 Mar 20
IPO registration
4:31pm
during 2020 that will further broaden and strengthen our academic expert network. Our cutting-edge liquid biopsy technology, ICP, enables detection
10-K
2019 FY
PRPO Precipio Inc
27 Mar 20
Annual report
3:47pm
into additional partnerships with premiere academic institutions during 2020 that will further broaden and strengthen our academic expert network. Our cutting
424B3
PRPO Precipio Inc
30 Jan 20
Prospectus supplement
5:09pm
broaden and strengthen our academic expert network, although there is no guarantee that such partnership opportunities will be available. Our cutting
S-1/A
PRPO Precipio Inc
27 Jan 20
IPO registration (amended)
4:47pm
our academic expert network, although there is no guarantee that such partnership opportunities will be available. Our cutting-edge liquid biopsy
S-1
PRPO Precipio Inc
14 Jan 20
IPO registration
4:26pm
partnerships with premiere academic institutions during 2019 that will potentially broaden and strengthen our academic expert network, although
424B3
PRPO Precipio Inc
21 Aug 19
Prospectus supplement
5:28pm
into additional partnerships with premiere academic institutions during 2019 that will potentially broaden and strengthen our academic expert network
S-1
PRPO Precipio Inc
9 Aug 19
IPO registration
3:47pm
and strengthen our academic expert network, although there is no guarantee that such partnership opportunities will be available. Our cutting-edge liquid
DEF 14A
PRPO Precipio Inc
29 Apr 19
Definitive proxy
5:22pm
that Mr. Riccitelli, Dr. Fisher and Ms. LaPorte each qualifies as an “audit committee financial expert” under the rules adopted by the SEC
10-K
2018 FY
PRPO Precipio Inc
16 Apr 19
Annual report
5:20pm
academic institutions during 2019 that will further broaden and strengthen our academic expert network. Our cutting-edge liquid biopsy technology, ICP